Physician profile
Darin J Awaya
NPI 1477544633
$445,121.48
in general payments reported to CMS, 2019-2025
10 companies · $113K in 2025
The $113K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,307 · 2020: $42K · 2021: $45K · 2022: $49K · 2023: $90K · 2024: $97K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $298K · Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $297,773.18 |
| Food and Beverage | $1,601.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hyhte Holdings INC. | $429,238.97 | 2019-2025 | Half Dome X |
| Globus Medical, INC. | $6,984.10 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $5,764.93 | 2019-2024 | Vital, C-Tek Maxan, Intergro Dbm Plus |
| Amgen INC. | $1,551.25 | 2019-2025 | Evenity, Prolia |
| Medtronic, INC. | $749.83 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Zimvie INC. | $377.81 | 2022 | |
| Medtronic USA, INC. | $277.84 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $124.52 | 2021 | |
| Radius Health, INC. | $32.72 | 2019 | |
| Lemaitre Vascular, INC. | $19.51 | 2025 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Awaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.